South Korea’s tech giant, Samsung Group recently announced its plan to invest $205 billion (240 trillion won) in its semiconductor, biopharmaceuticals and telecommunications units over the next three years. The investment will be focused on enhancing its global presence and lead in new industries such as next-generation telecommunication and robotics.
The investment will be led by Samsung affiliates including Samsung Electronics and Samsung Biologics.
This investment will also be used to strengthen its technology and leadership position in the market through mergers and acquisitions.
Samsung Electronics plans to develop advanced process technology and expand the business with AI and data centers for its system semiconductors. It will also focus on up-to-date technology such as EUV-based sub-14-nanometer DRAM and over 200-layer V-NAND products for the memory business, reported TechCrunch. In May this year, Samsung announced making investment of $151 billion in its logic chip and foundry sector, to be the top logic chip maker by 2030.
The company also reported in a statement that Samsung Biologics and Samsung Bioepis plan to establish two new plants, and a fourth factory that is under construction, for expanding the contract development manufacturing organization (CDMO) business.
Samsung has set aside $154.3 billion (180 trillion won) for home ground. It expects to create 40,000 new jobs by 2023 through this investment.